BioSig Technologies, Inc. STEX Deferred Tax Assets In Research Development Tax Credit
Deferred Tax Assets In Research Development Tax Credit at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept STEX:DeferredTaxAssetsInResearchDevelopmentTaxCredit.
The official record: BioSig Technologies, Inc.’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s deferred tax assets in research development tax credit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s deferred tax assets in research development tax credit?
- BioSig Technologies, Inc. (STEX) reported deferred tax assets in research development tax credit of $98K in Q4 2025.
- What does deferred tax assets in research development tax credit mean?
- This metric represents the value of tax credits generated from research and development activities that are carried forward to offset future tax liabilities. It reflects the company's investment in innovation and its ability to reduce future cash tax outflows through accumulated tax incentives. Investors monitor this to assess the potential for future tax savings resulting from past technological development efforts.